Oxford Asset Management: Oxford Asset Management Purchases New Position in Avalanche Biotechnologies Inc. (ADVM)

Oxford Asset Management purchased a new position in Avalanche Biotechnologies Inc. (NASDAQ:ADVM) during the second quarter, according to its most recent filing with the SEC. The fund purchased 60,477 shares of the company's stock, valued at approximately $191,000. Oxford Asset Management owned about 0.22% of Avalanche Biotechnologies at the end of the most recent reporting [...]